Cabergoline and interstitial lung disease Patient Reports February 12, 2012

Cabergoline Side Effects Report #4589518-9
Cabergoline side effect was reported by a Consumer or non-health professional from on Feb 04, 2005. Female patient, 85 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, oxygen saturation decreased, pleural effusion. Cabergoline dosage: 1 MG, ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4607408-X
Cabergoline side effect was reported by a Physician from on Feb 25, 2005. Female patient, 85 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, oral intake reduced, somnolence, vomiting. Cabergoline dosage: 1 MG, ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4616878-2
Cabergoline side effect was reported by a Physician from on Mar 07, 2005. Female patient, 85 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: ileus, interstitial lung disease, oral intake reduced, somnolence, vomiting. Cabergoline dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SINEMET, OXYBUTYNIN CHLORIDE, SENNA LEAF, BUFFERIN, TALIPEXOLE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4631556-1
Cabergoline side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, 85 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, oral intake reduced, somnolence, vomiting. Cabergoline dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SINEMET, OXYBUTYNIN CHLORIDE, SENNA LEAF, BUFFERIN, TALIPEXOLE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4686735-4
Cabergoline side effect was reported by a Health Professional from on May 26, 2005. Male patient, 85 years of age, weighting 144.4 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease. Cabergoline dosage: unknown. During the same period patient was treated with NAUZELIN, EC DOPARL, MUCOSTA. Patient recovered.

Cabergoline Side Effects Report #5156861-4
Cabergoline side effect was reported by a Physician from JAPAN on Oct 02, 2006. Male patient, 84 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease. Cabergoline dosage: 0.75 MG (1 D), ORAL. During the same period patient was treated with MADOPAR, ARICEPT. Patient recovered.

Cabergoline Side Effects Report #5167219-6
Cabergoline side effect was reported by a Physician from JAPAN on Nov 17, 2006. Male patient, 84 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion, vomiting. Cabergoline dosage: 0.75 MG (3 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, NEUQUINON, BIOFERMIN R, GASMOTIN, FERROMIA, MADOPAR, ARICEPT. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5192002-5
Cabergoline side effect was reported by a Physician from JAPAN on Dec 11, 2006. Male patient, 84 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion. Cabergoline dosage: 0.75 MG (3 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, NEUQUINON, BIOFERMIN R, GASMOTIN, FERROMIA, MADOPAR, ARICEPT. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5079125-6
Cabergoline side effect was reported by a Physician from JAPAN on July 27, 2006. Male patient, 79 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion, pneumonia aspiration, pulmonary fibrosis , tuberculous pleurisy. Cabergoline dosage: 0.25 MG (0.25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PERINDOPRIL ERBUMINE, OLMETEC, LEVODOPA, SYMMETREL, NIVADIL, POSTERISANTE. Patient was hospitalized. Patient died on 07/19/2006.


Cabergoline Side Effects Report #5070326-X
Cabergoline side effect was reported by a Physician from JAPAN on July 19, 2006. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: collagen disorder, condition aggravated, interstitial lung disease, pneumonia aspiration, pneumonia bacterial. Cabergoline dosage: 2 MG (1 MG, 2 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5085931-4
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2006. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: c-reactive protein increased, collagen disorder, interstitial lung disease, oral intake reduced, oxygen saturation decreased, pneumonia aspiration, pneumonia bacterial, rheumatoid factor positive. Cabergoline dosage: 2 MG (1 MGL 2 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4681937-5
Cabergoline side effect was reported by a Pharmacist from on May 23, 2005. Male patient, 75 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease. Cabergoline dosage: 1.5 MG (1.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DROXIDOPA, NEODOPASOL, DEPAS, NAUZELIN, LASIX, LANIRAPID, WARFARIN. Patient died on 05/10/2005.

Cabergoline Side Effects Report #4688544-9
Cabergoline side effect was reported by a Pharmacist from on May 27, 2005. Male patient, 74 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anuria, blood pressure decreased, depressed level of consciousness, interstitial lung disease, respiratory arrest, respiratory failure. Cabergoline dosage: unknown. During the same period patient was treated with DROXIDOPA, NEODOPASOL, DEPAS, NAUZELIN, LASIX, LANIRAPID. Patient was hospitalized. Patient died on 05/10/2005.

Cabergoline Side Effects Report #4696161-X
Cabergoline side effect was reported by a Pharmacist from on June 06, 2005. Male patient, 74 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anuria, blood pressure decreased, cardiac failure, condition aggravated, depressed level of consciousness, interstitial lung disease, mitral valve disease, respiratory arrest, respiratory failure. Cabergoline dosage: unknown. During the same period patient was treated with DROXIDOPA, NEODOPASOL, DEPAS IETIZOLAM), NAUZELIN, LASIX, LANIRAID. Patient was hospitalized. Patient died on 05/10/2005.


Cabergoline Side Effects Report #5119974-9
Cabergoline side effect was reported by a Physician from JAPAN on Sept 20, 2006. Male patient, 73 years of age, weighting 90.39 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anorexia, emphysema, interstitial lung disease, pharyngeal erythema, pharyngolaryngeal pain. Cabergoline dosage: 0.5 MG (0.25 MG, 2 IN 1 D), ORAL. During the same period patient was treated with AMLODIPINE BESILATE, CANDESARTAN CILEXETIL, TICLOPIDINE, NICERGOLINE, IBUDILAST. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5101313-0
Cabergoline side effect was reported by a Physician from JAPAN on Aug 21, 2006. Male patient, 71 years of age, weighting 130.1 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dysphagia, interstitial lung disease, lung disorder, pleural effusion, pneumonia aspiration. Cabergoline dosage: 5 MG (0.25 MG, 4 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5101366-X
Cabergoline side effect was reported by a Physician from JAPAN on Aug 21, 2006. Male patient, 71 years of age, weighting 130.1 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dysphagia, interstitial lung disease, lung disorder, pleural effusion, pneumonia aspiration, productive cough. Cabergoline dosage: 5 MG (0.25 MG, 4 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5070124-7
Cabergoline side effect was reported by a Physician from JAPAN on July 18, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease. Cabergoline dosage: 1 MG (0.25 MG, 4 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5073000-9
Cabergoline side effect was reported by a Physician from JAPAN on July 21, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aspiration, dysphagia, interstitial lung disease, lung disorder, pleural effusion. Cabergoline dosage: 1 MG (0.25 MG,4 IN 1 D), ORAL. During the same period patient was treated with CARBIDOPA AND LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4587464-8
Cabergoline side effect was reported by a Physician from on Feb 02, 2005. Female patient, 69 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4614167-3
Cabergoline side effect was reported by a Physician from on Mar 03, 2005. Female patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, interstitial lung disease, pleural effusion. Cabergoline dosage: 3 MG (1 MG, 1 IN 3 D), ORAL. During the same period patient was treated with MADOPAR, TALIPEXOLE HYDROCHLORIDE, AMANTADINE, SELEGILINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5102783-4
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Aug 28, 2006. Male patient, 56 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, emphysema, increased upper airway secretion, interstitial lung disease, pleurisy, pulmonary fibrosis , pulmonary function test decreased. Cabergoline dosage: unknown. During the same period patient was treated with ELDEPRYL, REQUIP, SINEMET, COMTESS, SIFROL. Patient recovered.

Cabergoline Side Effects Report #4842850-3
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Nov 23, 2005. Male patient, 56 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, emphysema, interstitial lung disease, pleurisy, pulmonary fibrosis , pulmonary function test decreased. Cabergoline dosage: 6 MG (4 MG), ORAL. During the same period patient was treated with ELDEPRYL, REQUIP, SINEMET, COMTESS, SIFROL. Patient recovered.

Cabergoline Side Effects Report #4600664-3
Cabergoline side effect was reported by a Consumer or non-health professional from on Feb 22, 2005. Female patient, 51 years of age, weighting 134.5 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, refusal of treatment by patient. Cabergoline dosage: 0.25 MG, ORAL. During the same period patient was treated with SINEMET, SELEGELINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4615472-7
Cabergoline side effect was reported by a Physician from on Mar 04, 2005. Female patient, 51 years of age, weighting 134.5 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, refusal of treatment by patient. Cabergoline dosage: 0.25 MG DAILY, ORAL. During the same period patient was treated with SINEMET, SELEGELINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5584636-0
Cabergoline side effect was reported by a Physician from JAPAN on Dec 27, 2007. Female patient, weighting 81.57 lb, was diagnosed with parkinson's disease , insomnia, constipation , gastritis, neurosis and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac valve disease, interstitial lung disease. Cabergoline dosage: unknown. During the same period patient was treated with MENESIT, SYMMETREL, AMOBAN, MAGNESIUM OXIDE, MARZULENE S, DEPAS. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4585596-1
Cabergoline side effect was reported by a Consumer or non-health professional from on Feb 01, 2005. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET, SELEGELINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4680703-4
Cabergoline side effect was reported by a Health Professional from on May 20, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5022609-7
Cabergoline side effect was reported by a Physician from JAPAN on May 23, 2006. Male patient, 79 years of age, was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion, pulmonary fibrosis . Cabergoline dosage: unknown. During the same period patient was treated with COVERSYL, OLMETEC, LEVODOPA, SYMMETREL, NIVADIL. Patient recovered.


Cabergoline Side Effects Report #4674030-9
Cabergoline side effect was reported by a Pharmacist from on May 10, 2005. Female patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5510429-6
Cabergoline side effect was reported by a Physician from JAPAN on Oct 29, 2007. Female patient, 75 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5526903-2
Cabergoline side effect was reported by a Physician from JAPAN on Nov 15, 2007. Female patient, 75 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, interstitial lung disease. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.